EOM Pharmaceuticals Holdings, Inc. (IMUC)

IMUC Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Operating Activities

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-5.13	-5.15	-1.94
Other Operating Activities	2.46	2.51	0.11
Change in Accounts Payable	-0.16	0.32	0.18
Change in Other Net Operating Assets	0.03	0.01	-
Operating Cash Flow	-2.79	-2.31	-1.65
Operating Cash Flow Growth	-	-	-

Financing Activities

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Long-Term Debt Issued	-	2.5	-
Net Debt Issued (Repaid)	2.3	2.5	-
Issuance of Common Stock	-	-	2
Other Financing Activities	1.02	1.03	-
Financing Cash Flow	3.32	3.53	2

Net Cash Flow

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Net Cash Flow	0.54	1.22	0.35

Free Cash Flow

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Levered Free Cash Flow	-1.99	-1.5	-
Unlevered Free Cash Flow	-1.92	-1.48	-

Additional Metrics

Fiscal Year	TTM	FY 2021	FY 2020
Period Ending	Sep 30, 2022	Dec 31, 2021	Dec 31, 2020
Cash Interest Paid	0.08	0.01	-
Change in Working Capital	-0.13	0.33	0.18

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2022

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 30, 2026

Data Sources Report a data error